Ledger.Open graph →
SEC Form D · Amendment · filed December 14, 2017

Solace Lifesciences, Inc

Offering
$4.0M
Sold
$1.6M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
WILMINGTON, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

James M. Poole · Wilmington, DEExec · DirectorStephen C. Kujawa · Wilmington, DEDirectorDavid C. Pilzner · Wilmington, DEDirectorChristopher C. Gross · Wilmington, DEExec · DirectorGarrett C. Holloway · Wilmington, DEDirectorLori A. Hensler · Pittsburgh, PADirectorG. Thomas T. Hough · Warrendale, PAExec · DirectorPeter E. Madden · Warrendale, PADirectorCharles F. Mansfield, Jr · Warrendale, PAExec · DirectorJohn F. Donahue · Pittsburgh, PADirectorJ. Christopher Donahue · Pittsburgh, PADirectorJohn T. Collins · Warrendale, PAExec · DirectorDamian Manning · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗